Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
Omnicare Advances Court-Supervised Process While Continuing to Deliver Enhanced Value to Customers
Published: April 01, 2026 by: PRNewsWire
Sentiment: Neutral
Enters into Asset Purchase Agreement with GenieRx WOONSOCKET, R.I., April 1, 2026 /PRNewswire/ -- Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE: CVS), today announced it has entered into an asset purchase agreement with GenieRx Holdings LLC ("GenieRx"), a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services.
Read More
CVS to Grow Store Footprint This Year With 60 New Locations
Published: March 30, 2026 by: WSJ
Sentiment: Positive
The drugstore chain will open traditional stores, Target-based locations and pharmacy-only sites after years of significant downsizing.
Read More
CVS to Expand Retail Footprint After Shrinking for 4 Years
Published: March 30, 2026 by: PYMNTS
Sentiment: Positive
CVS Health plans to expand its retail footprint this year after contracting it over the past four years, Bloomberg reported Monday (March 30). The retail pharmacy chain plans to open 60 stores this year, including 20 small pharmacy-only sites, while closing “a few dozen locations,” the report said, citing CVS spokesperson Amy Thibault.
Read More
CVS Health's Discounted Buying Opportunity Is Here - Robust Fundamentals And Secure Dividends
Published: March 25, 2026 by: Seeking Alpha
Sentiment: Positive
Proposed flat reimbursement rates for Medicare Advantage pressure recovery prospects, with CVS likely to suffer enrollment declines from the higher premiums through FY2027. Despite so, their diversified healthcare segments are likely to support their sustainable operations, aided by the potentially healthier membership base at higher rates. Thanks to the industry-wide pessimism, CVS is now undervalued at FWD P/E of 9.97x and 3Y PEG of 0.85x, with it triggering a bull-case PT of $83.60.
Read More
CVS reaches insulin pricing settlement with FTC
Published: March 24, 2026 by: Reuters
Sentiment: Neutral
CVS Health said on Tuesday it has reached a proposed settlement agreement with the Federal Trade Commission on insulin pricing.
Read More
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
Published: March 24, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: March 19, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
CVS Health: Stop Catastrophizing, Start Believing - Here's Why
Published: March 06, 2026 by: Seeking Alpha
Sentiment: Positive
CVS Health Corporation is rated a Buy, with a bullish outlook for 2026–2027 driven by margin recovery and undervalued valuation metrics. CVS trades at attractive forward P/S (~0.25x) and P/E (~13x), with potential for >50% share price upside if Medicare Advantage margins recover. 2026 guidance projects improved Medical Benefit Ratio, rising GAAP EPS ($6.04), and margin expansion across all divisions despite flat revenues.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: March 04, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: February 18, 2026 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: February 17, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why CVS Health (CVS) is a Strong Growth Stock
Published: February 16, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
CVS Health: Why Margin Compression In Aetna Limits The Upside For 2026
Published: February 10, 2026 by: Seeking Alpha
Sentiment: Positive
CVS Health Corporation is rated a Hold, reflecting balanced risk and income potential amid persistent Medicare Advantage cost pressures. Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B. CVS Health's valuation is highly sensitive to margin changes, with exposure to Medicare Advantage limiting upside barring significant CMS rate increases.
Read More
CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS beats Q4 earnings and revenue estimates, but higher costs squeeze margins. Shares slip pre-market despite upbeat 2026 EPS guidance.
Read More
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
Published: February 10, 2026 by: Seeking Alpha
Sentiment: Neutral
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
Read More
CVS Health (CVS) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
CVS Health posts strong Q4 revenue, raises full-year guidance
Published: February 10, 2026 by: Proactive Investors
Sentiment: Positive
CVS Health Corp (NYSE:CVS) on Tuesday reported stronger-than-expected fourth-quarter revenue and adjusted earnings, driven by growth across its pharmacy, health services, and insurance businesses. The US pharmacy chain and health insurer said fourth-quarter revenue rose 8.2% to $105.7 billion, topping analysts' expectations of $103.6 billion.
Read More
CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.19 per share a year ago.
Read More
The CVS Earnings Bombshell That Has Investors Scrambling Right Now
Published: February 10, 2026 by: 24/7 Wall Street
Sentiment: Positive
CVS Health (NYSE: CVS) delivered a solid revenue beat in Q4 2025, though adjusted earnings declined year-over-year despite exceeding Wall Street expectations.
Read More
What Analyst Projections for Key Metrics Reveal About CVS Health (CVS) Q4 Earnings
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Read More
Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Neutral
CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.
Read More
CVS Health: Exploit The Sector Panic Ahead Of Earnings
Published: February 03, 2026 by: Seeking Alpha
Sentiment: Negative
CVS Health remains well-positioned despite a sector-wide selloff after disappointing Medicare rate increases and UnitedHealth's outlook. CVS's early restructuring, cost cuts, and reduced Medicare exposure have prepared it better than peers for current industry headwinds. At 10–11x forward earnings, CVS trades at a discount to peers, with potential for multiple expansion if execution continues.
Read More
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Published: January 30, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
UNH Stock vs. CVS
Published: January 15, 2026 by: Forbes
Sentiment: Negative
UnitedHealth‘s stock has significantly lagged behind competitors like CVS and Centene over the previous year. A detailed examination indicates strong profitability, with an LTM Operating Margin of 6%, combined with a moderate valuation, as reflected by a PE of 17.2 in contrast to CVS's 218.3.
Read More
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?
Published: January 13, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: January 13, 2026 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Published: January 12, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner
- Employees 300000